Myopia Control by Combining Auricular Acupoint and Atropine Eyedrops
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00457717|
Recruitment Status : Completed
First Posted : April 6, 2007
Last Update Posted : April 6, 2007
|Condition or disease||Intervention/treatment||Phase|
|Myopia||Drug: 0.25 % atropine Drug: 0.5 % atropine Procedure: 0.25 % atropine+auricular acupoints||Phase 1|
A total of 64 school-aged children with myopia, fulfilling eligibility criteria, were recruited. They were randomly assigned to three arms:
- 21 treated with the 0.25 % atropine each night (0.25A).
- 20 treated with the 0.5 % atropine each night (0.5A).
- 23 treated with 0.25 % atropine each night together with stimulation of auricular acupoints(0.25A+E).
This protocol was proceeded for at least 6 months.The differences in post-treatment effects of these three groups were statistically accessed.
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||60 participants|
|Intervention Model:||Parallel Assignment|
|Study Start Date :||July 2005|
|Actual Study Completion Date :||July 2006|
- the progression of myopia degree, axial length elongation of eye
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00457717
|China Medical University|
|Taichung City, Taiwan|
|Principal Investigator:||Shih-Liang Chang, PhD||China Medical University, Taiwan|